Characteristics & Business Summary
Innovacell Inc. develops, manufactures, and sells cell therapy and regenerative medicine products. The company's products include ICEF15, a cell treatment for urgent fecal incontinence; ICEF16, a cell therapy for leaky fecal incontinence; and ICES13, a cell...
Income Statement Highlights
(¥ Million, except EPS/DPS in ¥)
| Fiscal Period | FY 2025 |
|---|---|
| Net Sales | — |
| Operating Profit | -2,232 |
| Ordinary Profit | -2,854 |
| Net Profit | -2,855 |
| EPS | ¥-86 |
| DPS | ¥0 |
Balance Sheet & Valuation Highlights
Total Assets
¥5B
Net Assets (Equity)
¥-1B
Equity Ratio
-12.4%
ROE (Return on Equity)
—
Cash & Equivalents
¥4B
Interest-Bearing Debt
¥5B
Capital Expenditure (CapEx)
¥0B
Depreciation & Amort.
¥0B